Abstract
This study aimed to elicit patient- and treatment-related factors that can potentially predict treatment adherence in adult ADHD. Subjects who were over 18 and received a diagnosis of ADHD were included in the study. Chart review data of 102 subjects regarding demographics, medications, comorbidities, concomitant medications and domains of functional impairment were collected, and predictors were assessed using a binominal logistical regression model. One hundred and two patients (78.4 % male) with a mean age of 28.8 (SD = 9.8, range = 18–55) years were enrolled in the study. Childhood diagnosis of ADHD, agents used for treatment (MPH or atomoxetine), individual domains of dysfunction and use of additional psychotropic drugs were not found to be related to treatment adherence. Patients with a university education and those referred for family history of ADHD were more likely to adhere to treatment (p = 0.05 and 0.03, respectively). On the other hand, reasons for referral other than ADHD were significantly more frequently related to non-adherence (p = 0.02). Treatment noncompliance remains a significant problem despite therapeutic effects of medications. Identification of predictors of non-adherence can lead to heightened awareness of special populations at risk. We have found that prior awareness on ADHD (via past history/media/friends) leading to self/clinician referral to rule out ADHD and pervasiveness of symptoms across functional domains led to better compliance in our sample. Future research with prospective design utilizing objective tools for adherence is required.
Similar content being viewed by others
References
Adler LD, Nierenberg AA (2010) Review of medication adherence in children and adults with ADHD. Postgrad Med 122:184–191. doi:10.3810/pgm.2010.01.2112
Barkley RA (2005) Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment, vol 1. Guilford Press, New York
Biederman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 366:237–248. doi:10.1016/s0140-6736(05)66915-2
Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M (2006) Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry 67:524–540
Buitelaar JK et al (2011) Predictors of treatment outcome in adults with ADHD treated with OROS(R) methylphenidate. Prog Neuropsychopharmacol Biol Psychiatry 35:554–560. doi:10.1016/j.pnpbp.2010.12.016
Caisley H, Muller U (2012) Adherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: a systematic review. Eur Psychiatry J Assoc Eur Psychiatr 27:343–349. doi:10.1016/j.eurpsy.2012.01.002
Castells X, Cunill R, Capella D (2013) Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials. Eur J Clin Pharmacol 69:347–356. doi:10.1007/s00228-012-1390-7
Christensen L, Sasane R, Hodgkins P, Harley C, Tetali S (2010) Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin 26:977–989. doi:10.1185/03007991003673617
Darredeau C, Barrett SP, Jardin B, Pihl RO (2007) Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users. Hum Psychopharmacol 22:529–536. doi:10.1002/hup.883
Faraone SV, Glatt SJ (2010) A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 71:754–763. doi:10.4088/JCP.08m04902pur
Faul F, Erdfelder E, Lang AG, Buchner A (2007) G* Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175–191
Günay Ş, Savran C, Aksoy UM (2005) Erişkin dikkat eksikliği hiperaktivite ölçeğinin (adult add/adhd dsm ıv-based diagnostic screening and rating scale) dilsel eşdeğerlilik, geçerlik güvenirlik ve norm çalışması
Guy W (1976) The clinical global impression scale. In: The ECDEU assessment manual for psychopharmacology-Revised, vol DHEW Publ. no. ADM 76-338. Rockwile, MD, pp 218–222
Halmoy A, Fasmer OB, Gillberg C, Haavik J (2009) Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord 13:175–187. doi:10.1177/1087054708329777
Kessler RC et al (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163:716–723. doi:10.1176/appi.ajp.163.4.716
Kooij SJ et al (2010) European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD BMC psychiatry 10:67. doi:10.1186/1471-244x-10-67
Kooij JJ et al (2013) Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial. BMC Psychiatry 13:36. doi:10.1186/1471-244x-13-36
Lawson KA, Johnsrud M, Hodgkins P, Sasane R, Crismon ML (2012) Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Clin Ther 34(944–956):e944. doi:10.1016/j.clinthera.2012.02.021
Montano B (2004) Diagnosis and treatment of ADHD in adults in primary care. J Clin Psychiatry 65(Suppl 3):18–21
Murphy K, Barkley RA (1996) Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry 37:393–401
Olfson M, Marcus SC, Zhang HF, Wan GJ (2007) Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder. J Manag Care Pharm (JMCP) 13:570–577
Retz W, Rosler M (2009) The relation of ADHD and violent aggression: what can we learn from epidemiological and genetic studies? Int J Law Psychiatry 32:235–243. doi:10.1016/j.ijlp.2009.04.006
Safren SA, Duran P, Yovel I, Perlman CA, Sprich S (2007) Medication adherence in psychopharmacologically treated adults with ADHD. J Atten Disord 10:257–260. doi:10.1177/1087054706292165
Seixas M, Weiss M, Muller U (2012) Systematic review of national and international guidelines on attention-deficit hyperactivity disorder. J Psychopharmacol (Oxford, England) 26:753–765. doi:10.1177/0269881111412095
Sobanski E, Retz W, Fischer R, Ose C, Alm B, Hennig O, Rosler M (2014) Treatment adherence and persistence in adult ADHD: results from a twenty-four week controlled clinical trial with extended release methylphenidate. Eur Psychiatry J Assoc Eur Psychiatr 29:324–330. doi:10.1016/j.eurpsy.2013.08.004
Soendergaard HM et al (2015) Treatment dropout and missed appointments among adults with attention-deficit/hyperactivity disorder: associations with patient-and disorder-related factors. J Clin Psychiatry 1:478
Turgay A (1995) Adult ADHD screening and rating scale and structured interview guidelines. Integrative Therapy Institute Publication, Toronto, Ontario
Wilens TE (2004) Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin N Am 27:283–301. doi:10.1016/s0193-953x(03)00113-8
Wilens TE (2007) The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. J Clin Psychiatry 68(Suppl 11):4–8
Wong IC et al (2009) Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)—a pharmacoepidemiological and qualitative study. Health Technol Assess (Winchester, England) 13:iii–iv, ix–xi, 1–120. doi:10.3310/hta13490
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no financial affiliations to disclose.
Additional information
A part of the data was disclosed previously at the 4th Congress of UK Adult ADHD Network (UKAAN) Congress, London, UK, September 9–12, 2014.
Rights and permissions
About this article
Cite this article
Semerci, B., Taskıran, S., Tufan, E. et al. Factors predicting treatment adherence in patients with adult attention-deficit/hyperactivity disorder: a preliminary study. ADHD Atten Def Hyp Disord 8, 139–147 (2016). https://doi.org/10.1007/s12402-016-0194-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12402-016-0194-5